Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HW091077 tablets in refractory or unexplained chronic cough
CTR20261010Phase 2Active
- Sponsor
- Humanwell Innovative Drug R&D Center
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HW091077 in refractory chronic cough (RCC), chronic idiopathic cough (CIC), sponsored by Humanwell Innovative Drug R&D Center. Started Jul 2026; status: active.
02
Drugs
HW091077
03
Conditions
refractory chronic cough (RCC)chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on CTR20261010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261010.